AI and Cancer: Unlocking the Immune System (with Immunai’s Luis Voloch)
Azeem Azhar's Exponential View - Un pódcast de HBR Presents / Azeem Azhar
Categorías:
Today’s cancer therapies are difficult, expensive, and slow to create. But the combination of new computing and new biological technologies is leading to a better understanding of the human immune system, with the goal of offering a better class of cancer therapies. Azeem Azhar speaks with Immunai co-founder and chief technology officer Luis Voloch about how AI is unlocking the secrets of the immune system and opening new avenues for novel cancer treatments.
